Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giuseppe Portella

Showing results (1-10 of 98) with videos related to

Pageof 10
Sort By:
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|August 24, 2010
Multicentric evaluation of two chemiluminescent immunoassays for IgG and IgM antibodies towards Rubella virusGiuseppe Portella, Claudio Galli,
Expert Opinion on Therapeutic Targets|August 14, 2012
Oncolytic virotherapy with modified adenoviruses and novel therapeutic targetsGunnel Halldén, Giuseppe Portella
International Review of Cell and Molecular Biology|October 10, 2009
Molecular and cell biology of testicular germ cell tumorsPaolo Chieffi, Renato Franco, Giuseppe Portella
Expert Review of Molecular Diagnostics|April 21, 2016
Fourth generation assays for HIV testingLuca Vallefuoco, Claudia Mazzarella, Giuseppe Portella
Biomedicines|October 23, 2021
Cross Talk of Macrophages with Tumor Microenvironment Cells and Modulation of Macrophages in Cancer by VirotherapySarah Di Somma, Fabiana Napolitano, Giuseppe Portella, et al.
Cancers|October 23, 2019
Virotherapy as a Potential Therapeutic Approach for the Treatment of Aggressive Thyroid CancerAnna Maria Malfitano, Sarah Di Somma, Nella Prevete, et al.
Cancers|January 26, 2020
Reply to Comment on "Malfitano, A.M. et al. Virotherapy as a Potential Therapeutic Approach for the Treatment of Aggressive Thyroid Cancer" <i>Cancers</i> 2019, <i>11</i>, 1532Anna Maria Malfitano, Sarah Di Somma, Nella Prevete, et al.
Recent Patents on Anti-Cancer Drug Discovery|June 8, 2010
Aurora A and B kinases--targets of novel anticancer drugsSilvana Libertini, Antonella Abagnale, Carmela Passaro, et al.
The Journal of Clinical Endocrinology and Metabolism|June 7, 2002
ONYX-015, an E1B gene-defective adenovirus, induces cell death in human anaplastic thyroid carcinoma cell linesGiuseppe Portella, Stefania Scala, Donata Vitagliano, et al.
Biochimie|October 23, 2022
History of how viruses can fight cancer: From the miraculous healings to the approval of oncolytic virusesMaurizio Bifulco, Erika Di Zazzo, Fabiana Napolitano, et al.
Pageof 10

Showing results (1-10 of 98) with videos related to

Sort By:
Pageof 10
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|August 24, 2010
Multicentric evaluation of two chemiluminescent immunoassays for IgG and IgM antibodies towards Rubella virusGiuseppe Portella, Claudio Galli,
Expert Opinion on Therapeutic Targets|August 14, 2012
Oncolytic virotherapy with modified adenoviruses and novel therapeutic targetsGunnel Halldén, Giuseppe Portella
International Review of Cell and Molecular Biology|October 10, 2009
Molecular and cell biology of testicular germ cell tumorsPaolo Chieffi, Renato Franco, Giuseppe Portella
Expert Review of Molecular Diagnostics|April 21, 2016
Fourth generation assays for HIV testingLuca Vallefuoco, Claudia Mazzarella, Giuseppe Portella
Biomedicines|October 23, 2021
Cross Talk of Macrophages with Tumor Microenvironment Cells and Modulation of Macrophages in Cancer by VirotherapySarah Di Somma, Fabiana Napolitano, Giuseppe Portella, et al.
Cancers|October 23, 2019
Virotherapy as a Potential Therapeutic Approach for the Treatment of Aggressive Thyroid CancerAnna Maria Malfitano, Sarah Di Somma, Nella Prevete, et al.
Cancers|January 26, 2020
Reply to Comment on "Malfitano, A.M. et al. Virotherapy as a Potential Therapeutic Approach for the Treatment of Aggressive Thyroid Cancer" <i>Cancers</i> 2019, <i>11</i>, 1532Anna Maria Malfitano, Sarah Di Somma, Nella Prevete, et al.
Recent Patents on Anti-Cancer Drug Discovery|June 8, 2010
Aurora A and B kinases--targets of novel anticancer drugsSilvana Libertini, Antonella Abagnale, Carmela Passaro, et al.
The Journal of Clinical Endocrinology and Metabolism|June 7, 2002
ONYX-015, an E1B gene-defective adenovirus, induces cell death in human anaplastic thyroid carcinoma cell linesGiuseppe Portella, Stefania Scala, Donata Vitagliano, et al.
Biochimie|October 23, 2022
History of how viruses can fight cancer: From the miraculous healings to the approval of oncolytic virusesMaurizio Bifulco, Erika Di Zazzo, Fabiana Napolitano, et al.
Pageof 10